Commenting on her appointment, Ms
Contact:
VP
Investor Relations
T: +61 419 548 434
E: lisa.pendlebury@maynepharma.com
About
(C) 2022 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.24 AUD | +0.28% | +3.87% | +17.72% |
Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
Feb. 25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
Commenting on her appointment, Ms
Contact:
VP
Investor Relations
T: +61 419 548 434
E: lisa.pendlebury@maynepharma.com
About
(C) 2022 Electronic News Publishing, source
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
176.7 EUR | -0.12% | +1.24% | 150B | ||
56.87 EUR | +0.87% | +2.90% | 68.07B | ||
1st Jan change | Capi. | |
---|---|---|
+17.72% | 382M | |
+28.67% | 46.19B | |
+18.57% | 22.88B | |
+20.11% | 14.18B | |
+0.81% | 12.63B | |
+46.16% | 12.07B | |
-1.55% | 7.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.37% | 5.14B |